Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results From CALGB 100103/BMT CTN 0502

Blood (2012) 120 (21): 230.

https://doi.org/10.1182/blood.V120.21.230.230

Published: 2012

Journal Articles

Autologous Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Achieves Outcomes Similar to Allogeneic Transplantation - Results of CALGB 10001 (Alliance)

Meir Wetzler, MD, Dorothy Watson, B.S., Wendy Stock, MD, Kouros Owzar, PhD, Gregory Koval, B.S., Eva Hoke, John M McCarty, MD, William Blum, MD, Bayard L. Powell, MD, Guido Marcucci, MD, Clara D Bloomfield, Charles Linker, MD, Richard A. Larson, MD

Blood (2012) 120 (21): 816.

https://doi.org/10.1182/blood.V120.21.816.816

Published: 2012

Journal Articles

Phase III Intergroup Study of Lenalidomide Versus Placebo Maintenance Therapy Following Single Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Myeloma: CALGB 100104

Philip L. McCarthy, MD, Kouros Owzar, PhD, Kenneth C. Anderson, Craig C. Hofmeister, MD, David Duane Hurd, MD, Hani Hassoun, MD, Sergio Giralt, MD, Edward A. Stadtmauer, MD, Paul G Richardson, MD, Daniel J. Weisdorf, MD, Ravi Vij, MBBS, MD, Jan S Moreb, MD, Natalie Scott Callander, MD, Koen Van Besien, MD, Teresa Gentile, MD, PhD, Luis Isola, MD, Richard T Maziarz, MD, Don A. Gabriel, MD, PhD, Asad Bashey, MD, PhD, Heather Landau, MD, Thomas Martin, MD, Muzaffar H. Qazilbash, MD, Denise Levitan, MD, Brian McClune, MD, Vera Hars, MS, John Postiglione, BA, Chen Jiang, PhD, Elizabeth Bennett, BS, Susan S Barry, BA, Linda Bressler, PharmD, Michael Kelly, MA, Michele Sexton, MS, Cara Rosenbaum, MD, Hari Parameswaran, MD, MS, Marcelo C Pasquini, MD, MS, Mary M. Horowitz, MD, MS, Thomas C. Shea, MD, Steven M Devine, MD, Charles Linker, MD

Blood (2010) 116 (21): 37.

https://doi.org/10.1182/blood.V116.21.37.37

Published: 2010

Journal Articles

Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy In Adults with Hematopoietic Disorders Undergoing Matched Unrelated Donor Stem Cell Transplantation.

Adam Giermasz, MD, PhD, Lloyd E. Damon, MD, Lawrence D Kaplan, MD, Willis H. Navarro, MD, Kristen Hege, MD, Charles Linker, MD, Thomas Martin, MD

Blood (2010) 116 (21): 1317.

https://doi.org/10.1182/blood.V116.21.1317.1317

Published: 2010

Journal Articles

Long-Term Outcomes in Patients with Acute Myelogenous Leukemia (AML) Following Allogeneic Stem Cell Transplantation (AlloSCT) for Relapse After Initial Autologous Bone Marrow Transplant (ASCT).

Mary-Elizabeth Percival, MD, Lloyd E. Damon, MD, Thomas Martin, MD, Lawrence Kaplan, MD, Weiyun Ai, MD PhD, Jeffrey L. Wolf, MD, Sanghee Hong, Charles Linker, MD, Curt A. Ries, MD, Charalambos Andreadis, MD MSCE

Blood (2009) 114 (22): 2299.

https://doi.org/10.1182/blood.V114.22.2299.2299

Published: 2009

Journal Articles

Phase III Intergroup Study of Lenalidomide (CC-5013) Versus Placebo Maintenance Therapy Following Single Autologous Stem Cell Transplant for Multiple Myeloma (CALGB 100104): Initial Report of Patient Accrual and Adverse Events.

Philip L. McCarthy, MD, Kouros Owzar, PhD, Edward A. Stadtmauer, MD, Sergio Giralt, MD, David D Hurd, MD, Hani Hassoun, MD, Craig Hofmeister, MD, Paul Richardson, M.D., Ph.D., Daniel J. Weisdorf, Marcelo C. Pasquini, MD, Vera Hars, PhD, Michael Kelly, B.S., John Postiglione, Susan Sutherland, Kenneth C. Anderson, MD, Charles Linker, MD

Blood (2009) 114 (22): 3416.

https://doi.org/10.1182/blood.V114.22.3416.3416

Published: 2009

Journal Articles

HLA-Identical Sibling-Matched, CD34 + Selected, T Cell Depleted Peripheral Blood Stem Cells Following Myeloablative Conditioning for First or Second Remission Acute Myeloid Leukemia (AML): Results of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0303.

Steven M. Devine, MD, Robert J Soiffer, MD, Marcelo C. Pasquini, MD, Shelly Carter, Parameswaran N Hari, MD, MRCP, MS, Stephanie DeVore, Anthony Stein, Hillard M. Lazarus, MD, Charles Linker, MD, Edward A. Stadtmauer, MD, Carolyn A. Keever-Taylor, PhD, Richard J O'Reilly, MD

Blood (2009) 114 (22): 655.

https://doi.org/10.1182/blood.V114.22.655.655

Published: 2009

Journal Articles

A Prospective Multicenter Phase II Trial of Pentostatin in Adult Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease (cGvHD): A Cancer and Leukemia Group B/Eastern Cooperative Oncology Group Study.

Sherif Farag, MD, PhD, Kouros Owzar, PhD, Vera Hars, PhD, Hillard M. Lazarus, MD, Edward A. Stadtmauer, MD, Steven M Devine, MD, Koen van Besien, MD, Charles Linker, MD

Blood (2009) 114 (22): 2238.

https://doi.org/10.1182/blood.V114.22.2238.2238

Published: 2009

Journal Articles

Tacrolimus, Mini-Methotrexate and Mycophenolate Mofetil Is Safe and Effective as Acute Gvhd Prophylaxis for Non-Myeloablative Unrelated Donor Allogeneic Stem Cell Transplantation.

Sanghee Hong, Thomas Martin, MD, Lloyd E. Damon, MD, Lawrence Kaplan, MD, Willis H. Navarro, MD, Charles Linker, MD

Blood (2009) 114 (22): 1172.

https://doi.org/10.1182/blood.V114.22.1172.1172

Published: 2009

Journal Articles

Reduced Intensity Allogeneic Transplantation Provides High Disease-Free and Overall Survival in Patients (Pts) with Advanced Indolent NHL and CLL: CALGB 109901.

Thomas C. Shea, MD, Jeffrey Johnston, MA, William Walsh, MD, Sherif Farag, MD, PhD, John McCarty, MD, Asad Bashey, MD, PhD, Luis Isola, MD, Marc Stewart, MD, Michael Kelly, MA, Kouros Owzar, PhD, Charles Linker, MD

Blood (2007) 110 (11): 486.

https://doi.org/10.1182/blood.V110.11.486.486

Published: 2007

Journal Articles

A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease

Margaret L. MacMillan, Daniel Couriel, Daniel J. Weisdorf, Gisela Schwab, Nancy Havrilla, Thomas R. Fleming, Saling Huang, Lorin Roskos, Shimon Slavin, Richard K. Shadduck, John DiPersio, Mary Territo, Steve Pavletic, Charles Linker, Helen E. Heslop, H. Joachim Deeg, Bruce R. Blazar

Blood (2006) 109 (6): 2657–2662.

https://doi.org/10.1182/blood-2006-08-013995

Published: 2006

Journal Articles

Reduced-Intensity Allogeneic Transplantation after Failure of Autologous Transplantation: A Prospective Multi-Center CALGB Study.

Asad Bashey, MD, PhD, Kouros Owzar, PhD, Jeffrey L. Johnson, Steven M. Devine, MD, Richard K. Shadduck, MD, Thomas C. Shea, MD, Charles Linker, MD

Blood (2006) 108 (11): 3122.

https://doi.org/10.1182/blood.V108.11.3122.3122

Published: 2006

Journal Articles

Immuno-Chemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909.

Lloyd E. Damon, MD, Jeff Johnson, Donna Niedzwiecki, Bruce D. Cheson, MD, David Duane Hurd, MD, Nancy L. Bartlett, MD, John C. Byrd, Michael Kelly, Charles Linker, MD, George P. Canellos, MD

Blood (2006) 108 (11): 2737.

https://doi.org/10.1182/blood.V108.11.2737.2737

Published: 2006

Journal Articles

Phase I/II Study of Bortezomib in Combination with Liposomal Doxorubicin and Melphalan in Relapsed or Refractory Multiple Myeloma.

Ajai Chari, MD, Lawrence Kaplan, MD, Charles Linker, MD, Lloyd E. Damon, MD, Willis H. Navarro, MD, Thomas Martin, MD

Blood (2005) 106 (11): 5182.

https://doi.org/10.1182/blood.V106.11.5182.5182

Published: 2005

Journal Articles

A Retrospective Review of Outcomes of Patients with Chronic Myelomoncytic Leukemia Treated with 5-Azacitidine.

Anand Dhruva, MD, Lloyd E. Damon, MD, Charles Linker, MD, Thomas G. Martin, III, MD, Willis H. Navarro, MD

Blood (2005) 106 (11): 4931.

https://doi.org/10.1182/blood.V106.11.4931.4931

Published: 2005

Journal Articles

Eradication of Minimal Residual Disease during Treatment of Mantle Cell Lymphoma: CALGB 59909.

Dorie Sher, BS, Jeffrey Johnson, PhD, Mariah Siddiqui, Michael A. Caligiuri, MD, Lloyd E. Damon, MD, George P. Canellos, MD, Charles Linker, MD, Bruce D. Cheson, MD, Wendy Stock, MD

Blood (2004) 104 (11): 1652.

https://doi.org/10.1182/blood.V104.11.1652.1652

Published: 2004

Journal Articles

Intense Immunochemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909. A Preliminary Report.

Lloyd Damon, Donna Niedzwiecki, Jeff Johnson, Bruce Cheson, David Hurd, Nancy Barlett, Michael Kelly, Charles Linker, George Canellos

Blood (2004) 104 (11): 895.

https://doi.org/10.1182/blood.V104.11.895.895

Published: 2004

Journal Articles

Voriconazole Is Safe and Effective as Prophylactic Antifungal Therapy Following Allogeneic Transplantation.

Thomas Martin, MD, Meaghan Working, Ryan O’Malley, Joe Guglielmo, Neal Fischbach, MD, Lloyd Damon, MD, Willis Navarro, MD, Lawry Kaplan, MD, Richard Jacobs, John Andrews, Charles Linker, MD

Blood (2004) 104 (11): 5094.

https://doi.org/10.1182/blood.V104.11.5094.5094

Published: 2004

Journal Articles

Defibrotide as treatment for hepatic veno-occlusive disease

Charles Linker

Blood (2002) 100 (13): 4255.

https://doi.org/10.1182/blood-2002-10-3127

Published: 2002

Journal Articles

A Multicenter Study of Platelet Recovery and Utilization in Patients After Myeloablative Therapy and Hematopoietic Stem Cell Transplantation

Blood (1998) 91 (9): 3509–3517.

https://doi.org/10.1182/blood.V91.9.3509

Published: 1998

NARROW

A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results From CALGB 100103/BMT CTN 0502

Autologous Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Achieves Outcomes Similar to Allogeneic Transplantation - Results of CALGB 10001 (Alliance)

Phase III Intergroup Study of Lenalidomide Versus Placebo Maintenance Therapy Following Single Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Myeloma: CALGB 100104

Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy In Adults with Hematopoietic Disorders Undergoing Matched Unrelated Donor Stem Cell Transplantation.

Long-Term Outcomes in Patients with Acute Myelogenous Leukemia (AML) Following Allogeneic Stem Cell Transplantation (AlloSCT) for Relapse After Initial Autologous Bone Marrow Transplant (ASCT).

Phase III Intergroup Study of Lenalidomide (CC-5013) Versus Placebo Maintenance Therapy Following Single Autologous Stem Cell Transplant for Multiple Myeloma (CALGB 100104): Initial Report of Patient Accrual and Adverse Events.

HLA-Identical Sibling-Matched, CD34 + Selected, T Cell Depleted Peripheral Blood Stem Cells Following Myeloablative Conditioning for First or Second Remission Acute Myeloid Leukemia (AML): Results of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0303.

A Prospective Multicenter Phase II Trial of Pentostatin in Adult Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease (cGvHD): A Cancer and Leukemia Group B/Eastern Cooperative Oncology Group Study.

Tacrolimus, Mini-Methotrexate and Mycophenolate Mofetil Is Safe and Effective as Acute Gvhd Prophylaxis for Non-Myeloablative Unrelated Donor Allogeneic Stem Cell Transplantation.

Reduced Intensity Allogeneic Transplantation Provides High Disease-Free and Overall Survival in Patients (Pts) with Advanced Indolent NHL and CLL: CALGB 109901.

A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease

Reduced-Intensity Allogeneic Transplantation after Failure of Autologous Transplantation: A Prospective Multi-Center CALGB Study.

Immuno-Chemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909.

Phase I/II Study of Bortezomib in Combination with Liposomal Doxorubicin and Melphalan in Relapsed or Refractory Multiple Myeloma.

A Retrospective Review of Outcomes of Patients with Chronic Myelomoncytic Leukemia Treated with 5-Azacitidine.

Eradication of Minimal Residual Disease during Treatment of Mantle Cell Lymphoma: CALGB 59909.

Intense Immunochemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909. A Preliminary Report.

Voriconazole Is Safe and Effective as Prophylactic Antifungal Therapy Following Allogeneic Transplantation.

Defibrotide as treatment for hepatic veno-occlusive disease

A Multicenter Study of Platelet Recovery and Utilization in Patients After Myeloablative Therapy and Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only